ANIP icon

ANI Pharmaceuticals
ANIP

Overview Fund Activity

229 hedge funds and large institutions have $1.28B invested in ANI Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 89 increasing their positions, 74 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
229
Holders Change
+2
Holders Change %
+0.88%
% of All Funds
3.07%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
28
Increased
89
Reduced
74
Closed
24
Calls
$1.37M
Puts
$874K
Net Calls
+$496K
Net Calls Change
+$824K

Top Buyers

1
NL
Nuveen LLC
North Carolina
+$21M
2
RCMNY
Rubric Capital Management (New York)
New York
+$13.1M
3
FGP
Freestone Grove Partners
California
+$12.5M
4
Millennium Management
Millennium Management
New York
+$12.1M
5
Teacher Retirement System of Texas
Teacher Retirement System of Texas
Texas
+$9.32M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$27.8M
2
Morgan Stanley
Morgan Stanley
New York
-$15.4M
3
SCM
Soleus Capital Management
Connecticut
-$11.3M
4
Nomura Holdings
Nomura Holdings
Japan
-$11.3M
5
WP
Woodline Partners
California
-$11.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
MG
251
Mather Group
Illinois
– -$2.08K -31 Closed
SW
252
SVB Wealth
Massachusetts
– -$1.67K -25 Closed
SC
253
Stephens Consulting
Michigan
– -$335 -5 Closed
7 8 9 10
11